EBS

Emergent BioSolutionsC

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

EBS vs peer average

45/100

EBS vs. peer average (C vs. C)

Grade spread

A 2 · B 3 · C 1 · D 2 · F 1

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

RIGL is the first available peer comparator.

Rigel is included only as a same-sector small-cap risk-appetite reference from the packet, not as a direct operating peer; the available peer set is therefore too loose to support a standard-conviction relative-valuation call.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerRIGLRigel

EBS

Emergent BioSolutions

RIGL

Rigel

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Mixed

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs RIGL

EBS / RIGL

Grade Position

In line

EBS vs. peer average (C vs. C)

45/100

Momentum

EBS

Value

RIGL

Sentiment

EBS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs EBS

RIGL

40/100

KMDA

60/100

Even

SGMT

Sagimet Biosciences Inc Class A Common

100/100

-2

EPRX

Eupraxia Pharmaceuticals Inc Common

80/100

-1

EDIT

Editas Medicine Inc Common

80/100

-1

RIGL is the first peer returned for this comparison set.